Phase II study for BC 007 in the indication Long COVID to start in June BERLIN, June 15, 2023 /PRNewswire/…
Browsing: biotechnology
SOUTH SAN FRANCISCO, Calif., May 25, 2023 /PRNewswire/ — Human Immunology Biosciences (HI-Bio™), a clinical-stage biotechnology company developing targeted therapies…
NEW YORK, April 29, 2023 /PRNewswire/ — Aquavit Holdings (Aquavit), a biotechnology company focused on the development of botulinum toxin…